Literature DB >> 20359475

Proteomics-based identification of haptoglobin as a novel plasma biomarker in oral squamous cell carcinoma.

Chih-Ho Lai1, Nai-Wen Chang, Chin-Fen Lin, Chia-Der Lin, Ying-Ju Lin, Lei Wan, Jim Jinn-Chyuan Sheu, Shih-Yin Chen, Yi-Ping Huang, Yu-Ting Sing, Tse-Wen Tao, Cheng-Kuo Lai, Ming-Hsui Tsai, Hong-Lin Chan, Yu-Jen Jou, Cheng-Wen Lin.   

Abstract

BACKGROUND: Identification of tumor biomarkers to assist early diagnosis and monitoring of disease progression may potentially decrease the mortality and morbidity associated with oral cancer.
METHODS: A mouse model with oral squamous cell carcinoma (OSCC) induced by 4-nitroquinoline 1-oxide (4-NQO)/arecoline in drinking water was established to discover stage-associated biomarkers. A proteomics approach, immunoblot and immunohistochemical analysis were used to validate the expressed biomarkers in mice with OSCC. Human plasma samples were also collected and candidate biomarkers were evaluated using enzyme-linked immunosorbent assay.
RESULTS: Proteomic profiling of mouse plasma samples indicated that haptoglobin and apolipoprotein A1 precursor were up-regulated in the mice with OSCC. Immunoblotting of plasma samples and immunohistochemical analysis of oral tissues showed a significantly higher level of haptoglobin in the OSCC mice than in the control mice. The expression of haptoglobin in human plasma samples from 52 patients with OSCC indicated a strong correlation between the increasing levels of haptoglobin and the clinical stages of OSCC (P<0.01).
CONCLUSIONS: These results suggest that haptoglobin has a great potential as a sensitive plasma biomarker for early detection of patients with OSCC. Crown Copyright 2010. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359475     DOI: 10.1016/j.cca.2010.03.028

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

1.  Blood Serum Zonulin in Colorectal Cancer, Autoimmune Bowel Diseases, and Irritable Bowel Syndrome.

Authors:  N E Kushlinskii; E S Gershtein; N N Zybina; P V Tsarapaev; E P Salyanova; E A Korotkova; E L Nikonov; Z Z Mamedli; V K Bozhenko; I S Stilidi
Journal:  Bull Exp Biol Med       Date:  2022-07-19       Impact factor: 0.737

2.  Correspondence between salivary proteomic pattern and clinical course in primary Sjögren syndrome and non-Hodgkin's lymphoma: a case report.

Authors:  Chiara Baldini; Laura Giusti; Federica Ciregia; Ylenia Da Valle; Camillo Giacomelli; Elena Donadio; Francesco Ferro; Sara Galimberti; Valentina Donati; Laura Bazzichi; Stefano Bombardieri; Antonio Lucacchini
Journal:  J Transl Med       Date:  2011-11-02       Impact factor: 5.531

3.  Heterotropic Effect of β-lactam Antibiotics on Antioxidant Property of Haptoglobin (2-2)-Hemoglobin Complex.

Authors:  Masoumeh Tayari; Zahra Moosavi-Nejad; Fatemeh Moosavi Nejad; Mostafa Rezaei-Tavirani; Marzieh Dehghan Shasaltaneh
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

4.  Estimation of serum β2-microglobulin in potentially malignant disorders and squamous cell carcinoma of the oral cavity: A clinicopathological study.

Authors:  Anand Pratap Singh; Nitin Kumar; Manthena Srinivasa Raju; Narendra Nath Singh; Suma Gundareddy Nagendrareddy
Journal:  Dent Res J (Isfahan)       Date:  2014-01

5.  Identification of host-immune response protein candidates in the sera of human oral squamous cell carcinoma patients.

Authors:  Yeng Chen; Siti Nuraishah Azman; Jesinda P Kerishnan; Rosnah Binti Zain; Yu Nieng Chen; Yin-Ling Wong; Subash C B Gopinath
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

Review 6.  Inflammatory Markers and MicroRNAs: The Backstage Actors Influencing Prognosis in Colorectal Cancer Patients.

Authors:  Rihab Nasr; Miza Salim Hammoud; Farah Nassar; Deborah Mukherji; Ali Shamseddine; Sally Temraz
Journal:  Int J Mol Sci       Date:  2018-06-26       Impact factor: 5.923

7.  Proteomic Profiling for Serum Biomarkers in Mice Exposed to Ionizing Radiation.

Authors:  Jinfeng Huang; Qi Wang; Yingchun Hu; Zhenhua Qi; Zhongwu Lin; Wantao Ying; Meijuan Zhou
Journal:  Dose Response       Date:  2019-12-12       Impact factor: 2.658

8.  c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.

Authors:  Ya-Chu Tang; Jenn-Ren Hsiao; Shih-Sheng Jiang; Jang-Yang Chang; Pei-Yi Chu; Ko-Jiunn Liu; Hsun-Lang Fang; Li-Mei Lin; Huang-Hui Chen; Yen-Wen Huang; Yu-Tsen Chen; Fang-Yu Tsai; Su-Fang Lin; Yung-Jen Chuang; Ching-Chuan Kuo
Journal:  Theranostics       Date:  2021-03-11       Impact factor: 11.556

Review 9.  Epithelial integrity, junctional complexes, and biomarkers associated with intestinal functions.

Authors:  Arash Alizadeh; Peyman Akbari; Johan Garssen; Johanna Fink-Gremmels; Saskia Braber
Journal:  Tissue Barriers       Date:  2021-10-30

10.  Evaluation of Haptoglobin Genotype and Some Risk Factors of Cancer in Patients with Early Stage Esophageal Cancer.

Authors:  Sara Hosseinzadeh; Reza Alipanah-Moghadam; Fazel Isapanah Amlashi; Ali Nemati
Journal:  Asian Pac J Cancer Prev       Date:  2019-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.